Main Street Capital Corporation vs MiniMed Group Inc. Common Stock — how do they compare? Main Street Capital Corporation trades at $54.03 (market cap $5.09B), while MiniMed Group Inc. Common Stock trades at $19.53 (market cap $5.57B). The key difference: Main Street Capital Corporation and MiniMed Group Inc. Common Stock are close in size by market cap, and Main Street Capital Corporation pays a 5.84% dividend while MiniMed Group Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Main Street Capital Corporation for 88 Days and MiniMed Group Inc. Common Stock for 0 Days on average.
| MAIN | MMED | |
|---|---|---|
Market Cap | $5.09B | $5.57B |
Volume | 524,060 | 23,336,073 |
Sector | Financials | Health |
52-Week High | $64.60 | $23.84 |
52-Week Low | $49.63 | $10.80 |
Typical Hold Time | 88 Days | 0 Days |
Enterprise Value | $7.54B | $5.37B |
Dividend Yield | 5.84% | — |
Signals from Pluang's Aura AI — not financial advice
Main Street Capital (MAIN) trades at $54.305, up 0.23% on the day, with a bearish technical outlook as moving averages and oscillators signal selling pressure. Fundamentally, the company maintains strong profitability with an 80.77% net income margin and a P/E of 10.94, though revenue declined to $592 million in 2025 from $601 million in 2024. Recent earnings show mixed results, with a beat in Q2 2026 but a miss in Q1 2026. The stock pays consistent monthly dividends, with the latest being $0.27 per share.
The investment outlook is cautious; analyst consensus is a 'Hold' with a $58.33 price target, indicating modest upside. Risks include softening earnings, a premium valuation at 1.62x NAV, and sensitivity to interest rates. The bearish technicals and high hold ratings suggest limited near-term catalysts, but the dividend yield near 8% and robust ROE of 14.92% provide income support.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →